Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: Case report

Nephrology Dialysis Transplantation

Volumn 26, Issue 6, 2011, Pages 2044-2046

  Pillebout, Evangéline ^a   Rocha, Fabiane ^a   Fardet, Laurence ^a   Rybojad, Michel ^a   Verine, Jérôme ^a   Glotz, Denis ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Henoch Schonlein purpura; nephritis; rituximab; skin

Indexed keywords

FIBRIN; IMMUNOGLOBULIN A; RAMIPRIL; RITUXIMAB;

ADULT; ANAPHYLACTOID PURPURA; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG EFFICACY; FIBRIN DEPOSITION; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEPOSITION; IMMUNOMODULATION; KIDNEY BIOPSY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; PURPURA; REMISSION; SKIN BIOPSY; SKIN ULCER; TREATMENT OUTCOME; VESICULAR RASH;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; MALE; PURPURA, SCHOENLEIN-HENOCH; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958080014     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr137     Document Type: Article

References (10)

1. Pillebout E, Thervet E, Hill G et al. Henoch-Schonlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002; 13: 1271-1278. (Pubitemid 34441408)
2. ZaffanelloM, FanosV. Treatment-based literature of Henoch-Schonlein purpura nephritis in childhood. Pediatr Nephrol 2009; 24: 1901-1911.
3. Weiss PF, Feinstein JA, Luan X et al. Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review. Pediatrics 2007; 120: 1079-1087. (Pubitemid 350085543)
4. Chartapisak W, Opastirakul S, Hodson EM et al. Interventions for preventing and treating kidney disease in Henoch-Schonlein Purpura (HSP). Cochrane Database Syst Rev 20093: CD005128.
5. Pillebout E, Alberti C, Guillevin L et al. Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schonlein Purpura. Kidney Int 2010; 78: 495-502.
6. Donnithorne KJ, Atkinson TP, Hinze CH et al. Rituximab therapy for severe refractory chronic Henoch-Schonlein purpura. J Pediatr 2009; 155: 136-139.
7. Saulsbury FT. Clinical update: Henoch-Schonlein purpura. Lancet 2007; 369: 976-978.
8. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet 2002; 360: 666-670. (Pubitemid 35232334)
9. Lau KK, Suzuki H, Novak J et al. Pathogenesis of Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2010; 25: 19-26.
10. Levesque MC. Translational Mini-Review Series on B Cell-Directed Therapies: recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immunol 2009; 157: 198-208